Deep Convolutional Neural Networks for Detecting COVID-19 Using Medical Images: A Survey

Automated quantification of SARS-CoV-2 pneumonia with large vision model knowledge adaptation

Background

Large vision models (LVM) pretrained by large datasets have demonstrated their enormous capacity to understand visual patterns and capture semantic information from images. We proposed a novel method of knowledge domain adaptation with pretrained LVM for a low-cost artificial intelligence (AI) model to quantify the severity of SARS-CoV-2 pneumonia based on frontal chest X-ray (CXR) images.

Methods

Our method used the pretrained LVMs as the primary feature extractor and self-supervised contrastive learning for domain adaptation. An encoder with a 2048-dimensional feature vector output was first trained by self-supervised learning for knowledge domain adaptation. Then a multi-layer perceptron (MLP) was trained for the final severity prediction. A dataset with 2599 CXR images was used for model training and evaluation.

Results

The model based on the pretrained vision transformer (ViT) and self-supervised learning achieved the best performance in cross validation, with mean squared error (MSE) of 23.83 (95 % CI 22.67-25.00) and mean absolute error (MAE) of 3.64 (95 % CI 3.54-3.73). Its prediction correlation has theR 2 of 0.81 (95 % CI 0.79-0.82) and Spearman ρ of 0.80 (95 % CI 0.77-0.81), which are comparable to the current state-of-the-art (SOTA) methods trained by much larger CXR datasets.

Conclusion

The proposed new method has achieved the SOTA performance to quantify the severity of SARS-CoV-2 pneumonia at a significantly lower cost. The method can be extended to other infectious disease detection or quantification to expedite the application of AI in medical research.

Automatic Quantification of COVID-19 Pulmonary Edema by Self-supervised Contrastive Learning

We proposed a self-supervised machine learning method to automatically rate the severity of pulmonary edema in the frontal chest X-ray radiographs (CXR) which could be potentially related to COVID-19 viral pneumonia. For this we use the modified radiographic assessment of lung edema (mRALE) scoring system. The new model was first optimized with the simple Siamese network (SimSiam) architecture where a ResNet-50 pretrained by ImageNet database was used as the backbone. The encoder projected a 2048-dimension embedding as representation features to a downstream fully connected deep neural network for mRALE score prediction. A 5-fold cross-validation with 2,599 frontal CXRs was used to examine the new model's performance with comparison to a non-pretrained SimSiam encoder and a ResNet-50 trained from scratch. The mean absolute error (MAE) of the new model is 5.05 (95%CI 5.03-5.08), the mean squared error (MSE) is 66.67 (95%CI 66.29-67.06), and the Spearman's correlation coefficient (Spearman ρ) to the expert-annotated scores is 0.77 (95%CI 0.75-0.79). All the performance metrics of the new model are superior to the two comparators (P<0.01), and the scores of MSE and Spearman ρ of the two comparators have no statistical difference (P>0.05). The model also achieved a prediction probability concordance of 0.811 and a quadratic weighted kappa of 0.739 with the medical expert annotations in external validation. We conclude that the self-supervised contrastive learning method is an effective strategy for mRALE automated scoring. It provides a new approach to improve machine learning performance and minimize the expert knowledge involvement in quantitative medical image pattern learning.

Neural Networks for the Detection of COVID-19 and Other Diseases: Prospects and Challenges

Artificial neural networks (ANNs) ability to learn, correct errors, and transform a large amount of raw data into beneficial medical decisions for treatment and care has increased in popularity for enhanced patient safety and quality of care. Therefore, this paper reviews the critical role of ANNs in providing valuable insights for patients' healthcare decisions and efficient disease diagnosis. We study different types of ANNs in the existing literature that advance ANNs' adaptation for complex applications. Specifically, we investigate ANNs' advances for predicting viral, cancer, skin, and COVID-19 diseases. Furthermore, we propose a deep convolutional neural network (CNN) model called ConXNet, based on chest radiography images, to improve the detection accuracy of COVID-19 disease. ConXNet is trained and tested using a chest radiography image dataset obtained from Kaggle, achieving more than 97% accuracy and 98% precision, which is better than other existing state-of-the-art models, such as DeTraC, U-Net, COVID MTNet, and COVID-Net, having 93.1%, 94.10%, 84.76%, and 90% accuracy and 94%, 95%, 85%, and 92% precision, respectively. The results show that the ConXNet model performed significantly well for a relatively large dataset compared with the aforementioned models. Moreover, the ConXNet model reduces the time complexity by using dropout layers and batch normalization techniques. Finally, we highlight future research directions and challenges, such as the complexity of the algorithms, insufficient available data, privacy and security, and integration of biosensing with ANNs. These research directions require considerable attention for improving the scope of ANNs for medical diagnostic and treatment applications.